Breaking News Instant updates and real-time market news.

MYL

Mylan

$38.03

0.06 (0.16%)

16:59
10/05/16
10/05
16:59
10/05/16
16:59

Lawmakers: Report from CMS shows 'misclassification' of EpiPen as generic

Senate Finance Committee ranking member Ron Wyden and House Energy and Commerce Committee ranking member Frank Pallone issued a statement after receiving a letter from the Centers for Medicare & Medicaid Services regarding the "misclassification of EpiPen as a generic drug for nearly two decades." The letter from CMS "backs up" Wyden and Pallone's claim that EpiPen has been misclassified as a generic drug since the fourth quarter of 1997, despite "all evidence indicating it was a brand-name drug," according to the lawmakers. The letter also notes that Medicaid has spent nearly $800M on EpiPen since 2011, which includes the lower generic rebate of 13%, which the drug manufacturer is required to pay back to Medicaid. The correct rebate would have been at least 23.1%, plus an additional inflationary rebate. Reference Link

  • 07

    Oct

  • 28

    Mar

MYL Mylan
$38.03

0.06 (0.16%)

09/22/16
ARGS
09/22/16
NO CHANGE
ARGS
Mylan weakness creates good entry point, says Argus
After Mylan's stock fell 17% over the last month, Argus analyst Jacob Kilstein thinks that the stock has reached an attractive entry point, He says that the company's new generic EpiPen will cannibalize branded sales but should help it beat upcoming generic competitors. He thinks that the stock is undervalued and keeps a Buy rating on the stock.
09/23/16
BERN
09/23/16
NO CHANGE
BERN
Mylan generic Epipen to lower EPS by about 10%, says Bernstein
Bernstein analyst Aaron Gal estimates that Mylan's decision to introduce a generic version of its EpiPen will create a drag of about 10% on its EPS. After viewing the Congressional hearings on the device, Gal continues to believe that a competitor to EpiPen will hit the market before the end of 2018. He keeps a $60 price target and Outperform rating on Mylan.
09/30/16
LEER
09/30/16
NO CHANGE
Target $45
LEER
Outperform
Mylan price target cut to $45 on lower EpiPen estimates at Leerink
Leerink analyst Jason Gerberry lowered his EpiPen sales forecasts by 33-45% from 2017-2021 in light of recent company updates, including its plan to launch an authorized generic of the emergency treatment later this year. While Mylan "appears on the right side of the law" regarding the latest Medicaid rebate controversy, Gerberry believes investors should consider the risk of a future settlement related to the issue. He cut his price target on Mylan shares to $45 from $55, but keeps an Outperform rating on the stock as he sees cash flows being sufficient to justify the current price.
10/04/16
JPMS
10/04/16
NO CHANGE
Target $52
JPMS
Overweight
Mylan price target lowered to $52 from $62 at JPMorgan
JPMorgan analyst Chris Schott lowered his price target for Mylan to $52 saying he remains cautious on the shares over the near-term given the ongoing Epipen controversy. The analyst, however, views the stock as "very inexpensive" and keeps an Overweight rating on the name. Schott sees a limited long-term impact to his thesis from the Epipen controversy and believes Mylan's generics business is underappreciated. He maintains an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

NLNK

NewLink Genetics

$18.59

0.51 (2.82%)

, MRK

Merck

$62.55

0.405 (0.65%)

14:32
04/25/17
04/25
14:32
04/25/17
14:32
Hot Stocks
NewLink drops after panel questions Ebola vaccine efficacy »

Shares of NewLink…

NLNK

NewLink Genetics

$18.59

0.51 (2.82%)

MRK

Merck

$62.55

0.405 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 04

    May

  • 07

    May

  • 10

    May

  • 12

    May

  • 27

    May

  • 31

    May

  • 06

    Jun

  • 09

    Jun

  • 14

    Jun

X

U.S. Steel

$31.19

-0.01 (-0.03%)

14:31
04/25/17
04/25
14:31
04/25/17
14:31
Options
US Steel sees a large spread trade ahead of earnings »

US Steel sees a large…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

14:25
04/25/17
04/25
14:25
04/25/17
14:25
Conference/Events
Leerink healthcare analysts hold an analyst/industry conference call »

Healthcare Analysts…

WRI

Weingarten Realty

$33.75

-0.64 (-1.86%)

14:23
04/25/17
04/25
14:23
04/25/17
14:23
Recommendations
Weingarten Realty analyst commentary  »

Weingarten Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

DIS

Disney

$115.29

1.59 (1.40%)

14:19
04/25/17
04/25
14:19
04/25/17
14:19
Periodicals
Disney targets Star Wars, Frozen sequels for 2019, Deadline reports »

Disney has unveiled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
04/25/17
04/25
14:17
04/25/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
04/25/17
04/25
14:16
04/25/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUBB

Hubbell

$117.83

-3.7 (-3.04%)

14:14
04/25/17
04/25
14:14
04/25/17
14:14
Hot Stocks
Hubbell acquires connected home products maker iDevices »

iDevices announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 02

    May

  • 09

    May

  • 09

    May

  • 09

    May

TWTR

Twitter

$14.80

0.085 (0.58%)

14:13
04/25/17
04/25
14:13
04/25/17
14:13
Technical Analysis
Twitter technical comments before earnings »

Ahead of earnings news,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CL

Colgate-Palmolive

$74.15

0.49 (0.67%)

14:11
04/25/17
04/25
14:11
04/25/17
14:11
Options
Colgate attracts a call writer ahead of earnings »

Colgate attracts a call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 31

    May

SQ

Square

$18.11

0.26 (1.46%)

14:06
04/25/17
04/25
14:06
04/25/17
14:06
Options
Square call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 16

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

14:05
04/25/17
04/25
14:05
04/25/17
14:05
General news
NY Fed's overnight reverse repo totaled $117.0 B, with 45 counterparties »

NY Fed's overnight…

STX

Seagate

$49.42

1.16 (2.40%)

, WDC

Western Digital

$85.77

2.66 (3.20%)

14:00
04/25/17
04/25
14:00
04/25/17
14:00
Earnings
On The Fly: What to watch in data storage earnings reports »

Companies in the data…

STX

Seagate

$49.42

1.16 (2.40%)

WDC

Western Digital

$85.77

2.66 (3.20%)

MU

Micron

$26.57

-0.75 (-2.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 31

    May

  • 07

    Jun

  • 08

    Jun

14:00
04/25/17
04/25
14:00
04/25/17
14:00
General news
Stocks drifting at session highs in afternoon trading »

Stocks have been sharply…

MTBC

Medical Transcription Billing

$0.42

-0.03 (-6.67%)

13:57
04/25/17
04/25
13:57
04/25/17
13:57
Hot Stocks
Medical Transcription Billing partners with Health Compliance Network »

MTBC announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$8.89

0.18 (2.07%)

13:54
04/25/17
04/25
13:54
04/25/17
13:54
Hot Stocks
Sprint promotion adds free fifth line to unlimited offer »

Sprint announced that for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

CMA

Comerica

$70.14

0.03 (0.04%)

13:53
04/25/17
04/25
13:53
04/25/17
13:53
Hot Stocks
Comerica raises quarterly dividend 13% to 26c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WFC

Wells Fargo

$54.57

0.92 (1.71%)

13:51
04/25/17
04/25
13:51
04/25/17
13:51
Hot Stocks
Wells Fargo chairman: Stockholders sent board 'clear message of dissatisfaction' »

Commenting on the results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

D

Dominion

$77.54

-0.53 (-0.68%)

13:51
04/25/17
04/25
13:51
04/25/17
13:51
Options
Downside put buyers in Dominion Resources ahead of earnings »

Downside put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 10

    May

  • 21

    May

WFC

Wells Fargo

$54.59

0.935 (1.74%)

13:50
04/25/17
04/25
13:50
04/25/17
13:50
Hot Stocks
Wells Fargo confirms all directors reelected, says votes dip as low as 53% »

Wells Fargo announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

PG

Procter & Gamble

$89.97

0.415 (0.46%)

13:48
04/25/17
04/25
13:48
04/25/17
13:48
Technical Analysis
Procter & Gamble technical comments before earnings »

Ahead of earnings news,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

XLNX

Xilinx

$60.65

2.96 (5.13%)

13:46
04/25/17
04/25
13:46
04/25/17
13:46
Options
Xilinx call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVHY

Vivendi

$20.34

1.39 (7.34%)

13:45
04/25/17
04/25
13:45
04/25/17
13:45
Periodicals
Vivendi's UMG valued at $22B by banks seeking float, Reuters says »

Bankers aiming to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHIY

Hitachi

$53.93

0.09 (0.17%)

, KKR

KKR

$17.51

0.25 (1.45%)

13:45
04/25/17
04/25
13:45
04/25/17
13:45
Periodicals
Hitachi plans to sell chipmaking device unit to KKR, JIP, Nikkei reports »

Hitachi (HTHIY) is…

HTHIY

Hitachi

$53.93

0.09 (0.17%)

KKR

KKR

$17.51

0.25 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

CLRO

ClearOne

$10.00

0.1 (1.01%)

13:43
04/25/17
04/25
13:43
04/25/17
13:43
Hot Stocks
ClearOne says awarded patent on 'beamforming' echo cancellation »

ClearOne announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.